Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by Dude51on Feb 11, 2021 7:04pm
323 Views
Post# 32547947

Folks if you do not have plans to buy more shares yur

Folks if you do not have plans to buy more shares yurgoing to be pissssed. Alice here we come. We made the right move on this one folks mark my words; Dude51 says this is one hell of an investment, patients is key.

Okay Robert you have my permission as a shareholder, you have my permission to buy out this  small start up company. I really must insist that we get with these folks el pronto.
I do not see a down side and I know you like to buy companies, 3rd time a charm? Talk with Mr. Salzman, get working on this acquisition,  you want to see a stock go ballistic? Do it, you can do it....
Even if we do not buy this start up company the fact were developing along the same line is huge.

https://omny.fm/shows/charles-adler-tonight/a-canadian-company-s-promising-solution-to-the-cov

GLTA
<< Previous
Bullboard Posts
Next >>